🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial.

9 citations

Jing Yang, Richard Van, Fan Yang, Yue Yu, Astra Yu +16 more

5 citations

Yue Yu, Shi Kuang, Biyue Zhu, Heng Zhou, Shaoqing Zhang +4 more

N/A
0DataRank · unranked
128 citations

Jin He, Duc-hiep Bach, Yung-hsing Huang, Zongwei Li, Huan Liu +3 more

9 citations

Haley Varnum, Catherine Getty, Natalie Loui, Ju Chen, Martin L. Kirk +3 more

N/A
0DataRank · unranked
0 citations

Kathleen R. Ran, Wenzhe Ma, Lucy Chen, Cindy Chen, Can Zhang +4 more

0 citations

Connor Nelson, Delanie Huntoon, Jing Yang, Martin Kirk, Simon J. George +4 more

121 citations

Wei Yin, Richard Van, Keyi Yin, Peng Wang, Chao Zheng +7 more

0 citations

Dora Evelyn Ibarra, Jing Yang, Haichen Zhang, A. John Barrett, E L Kaplan +13 more

8 citations

Jing Yang, Eric M. Gale, Huan Wang, Ivan Luptak, Howard H. Chen +8 more